Treatment with mesenchymal stem cells reverses lipid accumulation in steatotic cirrhotic liver
Mesenchymal stem cell (MSC) therapy shows promise in reversing liver fat accumulation (steatosis) in cirrhosis. Our analysis reveals MSC treatment significantly reduces hepatic lipid content, offering a potential novel therapeutic approach for this challenging condition. {CONTENT} explores the mechanisms and clinical implications.